News

Filter

1 to 9 of 10 results

BioAlliance’s Sitavig debuts in USA; new patent granted

BioAlliance’s Sitavig debuts in USA; new patent granted

22-07-2014

French drug developer BioAlliance Pharma says that its US partner Innocutis Holdings has launched Sitavig…

Anti-viralsBioAlliance PharmaBiotechnologyHealth Medical PharmaHerpesInnocutis HoldingsLabial herpesMarkets & MarketingMedicineMicrobiologyPatentsSitavigUSA

BioAlliance and Topotarget progress merger plan

BioAlliance and Topotarget progress merger plan

01-07-2014

France-base BioAlliance Pharma and Denmark’s Topotarget say that the shareholders of both companies…

BioAlliance PharmaBiotechnologyMergers & AcquisitionsOncologyOnxeoTopotarget

Definitive merger plan between BioAlliance Pharma and Topotarget

Definitive merger plan between BioAlliance Pharma and Topotarget

22-05-2014

French orphan drug developer BioAlliance Pharma and Denmark’s Topotarget have confirmed details of…

BioAlliance PharmaBiotechnologyMergers & AcquisitionsOncologyOnxeoTopotarget

BioAlliance Pharma licenses Sitavig to Innocutis in North America

19-03-2014

French drug developer BioAlliance Pharma has executed a licensing accord with the USA’s Innocutis Holdings…

Anti-viralsBioAlliance PharmaBiotechnologyInnocutis HoldingsLicensingNorth AmericaSitavig

BioAlliance Pharma extends Ph II Validive trial to USA

19-02-2013

French biotech firm BioAlliance Pharma (Euronext Paris - BIO) has announced the extension of its Phase…

BioAlliance PharmaBiotechnologyclonidine LauriadOncologyResearchValidive

BioAlliance says partner Vestiq debuts Oravig in USA

08-01-2013

French biotech firm BioAlliance Pharma (Euronext Paris - BIO) has announces the launch of Oravig (miconazole…

BioAlliance PharmaBiotechnologyLoramycMarkets & MarketingNorth AmericaOncologyOravigPharmaceuticalVestiq Pharmaceuticals

BioAlliance gains registration of Sitavig in eight European countries

20-12-2012

French biotech firm BioAlliance Pharma (Euronext Paris: BIO) has announced the approval of Sitavig (acyclovir…

Anti-viralsBioAlliance PharmaBiotechnologyEuropeRegulationSitavig

BioAlliance's Sitavig NDA "receivable" by US FDA

30-05-2012

French biotech firm BioAlliance Pharma (Euronext Paris: BIO) has announced the receivability of its Sitavig…

Anti-viralsBioAlliance PharmaBiotechnologyNorth AmericaRegulationSitavigSitavir

1 to 9 of 10 results

Back to top